September 20, 2026

Chemotherapy and Targeted Therapy

Novo Nordisk’s Ziltivekimab Hits Roadblock: Phase 3 ZEUS Trial Fails to Meet Primary Endpoint novo-nordisks-ziltivekimab-hits-roadblock-phase-3-zeus-trial-fails-to-meet-primary-endpoint

Novo Nordisk’s Ziltivekimab Hits Roadblock: Phase 3 ZEUS Trial Fails to Meet Primary Endpoint

Layla Zulfa September 3, 2026
In a significant setback for its burgeoning cardiovascular pipeline, Novo Nordisk has announced that ziltivekimab—an investigational human...
Read More Read more about Novo Nordisk’s Ziltivekimab Hits Roadblock: Phase 3 ZEUS Trial Fails to Meet Primary Endpoint
Public Health at a Crossroads: White House Executive Order Reshapes Childhood Vaccination Strategy Amid Measles Resurgence public-health-at-a-crossroads-white-house-executive-order-reshapes-childhood-vaccination-strategy-amid-measles-resurgence

Public Health at a Crossroads: White House Executive Order Reshapes Childhood Vaccination Strategy Amid Measles Resurgence

Reynand Wu September 3, 2026
By Editorial Staff The United States public health landscape is undergoing its most significant structural shift in...
Read More Read more about Public Health at a Crossroads: White House Executive Order Reshapes Childhood Vaccination Strategy Amid Measles Resurgence
A Regulatory Rollercoaster: UniQure’s High-Stakes Pursuit of Huntington’s Gene Therapy Approval a-regulatory-rollercoaster-uniqures-high-stakes-pursuit-of-huntingtons-gene-therapy-approval

A Regulatory Rollercoaster: UniQure’s High-Stakes Pursuit of Huntington’s Gene Therapy Approval

Nana Wu September 2, 2026
After an exceptionally volatile year characterized by internal FDA friction, high-profile resignations, and shifting scientific paradigms, biotechnology...
Read More Read more about A Regulatory Rollercoaster: UniQure’s High-Stakes Pursuit of Huntington’s Gene Therapy Approval
Navigating the New FDA Regulatory Landscape: A Comprehensive Guide to Finalized PDUFA Meeting Guidance navigating-the-new-fda-regulatory-landscape-a-comprehensive-guide-to-finalized-pdufa-meeting-guidance

Navigating the New FDA Regulatory Landscape: A Comprehensive Guide to Finalized PDUFA Meeting Guidance

Laily UPN September 2, 2026
The U.S. Food and Drug Administration (FDA) has officially finalized its long-anticipated guidance regarding formal meetings between...
Read More Read more about Navigating the New FDA Regulatory Landscape: A Comprehensive Guide to Finalized PDUFA Meeting Guidance
The Architect of the AI Hospital: How Sheba Medical Center Became OpenAI’s First International Healthcare Partner the-architect-of-the-ai-hospital-how-sheba-medical-center-became-openais-first-international-healthcare-partner

The Architect of the AI Hospital: How Sheba Medical Center Became OpenAI’s First International Healthcare Partner

Laily UPN September 2, 2026
In the rapidly evolving landscape of medical technology, a pivotal shift is occurring within the walls of...
Read More Read more about The Architect of the AI Hospital: How Sheba Medical Center Became OpenAI’s First International Healthcare Partner

You may have missed

the-great-insurance-debate-dissecting-the-role-of-health-insurers-in-americas-fiscal-crisis

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Muslim September 20, 2026
beyond-the-cream-how-a-fathers-quest-for-relief-sparked-a-skincare-revolution-2

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Lina Hope September 20, 2026
salk-scientists-unveil-estrogen-related-receptors-as-key-to-unlocking-energy-metabolism-and-combating-muscle-fatigue

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

Ammar Sabilarrohman September 20, 2026
the-architecture-of-hope-mapping-the-centuries-long-evolution-of-breast-cancer-treatment

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment

Suro Senen September 20, 2026